Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL28B-guided treatment duration trial in chronic hepatitis C genotype 1b
ChiCTR-TRC-11001413Phase 4Completed
- Sponsor
- Army Medical University
- Start
- Jan 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pegylated interferon alpha and ribavirin in hepatitis C virus infection (4 arms), sponsored by Army Medical University. Primary endpoints: IL28B genotype and sustained virological response. Started Jan 2011; status: completed.
02
Drugs
pegylated interferon alpharibavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on ChiCTR-TRC-11001413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001413.